Taglich's Company Profile for:
Receive email alerts
for this company
|
|
Intellipharmaceutics International Inc.
|
Symbol:
IPCI
Analyst:
Juan Noble
Taglich Rating:
Not Rated
Price Target:
NA
Time Horizon:
NA
Rating Established:
October 26, 2010
Price When Established:
$3.02
Most Recent Report:
February 3, 2012
Price When Issued:
$3.21
|
What's New
New information will be posted soon...
Company Description
Intellipharmaceutics develops pharmaceuticals, both generic and branded, which utilize proprietary controlled-release drug delivery technologies known collectively as Hypermatrix. These technologies provide a variety of release capabilities that are configured according to a drug candidate’s physical and chemical characteristics, its therapeutic use and the optimal site for release in the gastrointestinal tract. These technologies have been evaluated in bioavailability/bioequivalence studies of orally administered small molecule drugs developed to treat cardiovascular, central nervous system and gastrointestinal disorders. These formulations are also useful in the treatment of pain and diabetes.
The company has 15 drug candidates in its pipeline, five of which have been disclosed. Eleven are generic controlled-release drugs and four are new drugs that are controlled-release versions of immediate-release products. The company’s lead (by estimated launch date) pipeline product, an extended release version of dexmethylphenidate hydrochloride, is being commercialized in partnership with Par Pharmaceuticals, an established US generic drug manufacturer. So far, three Abbreviated New Drug Applications (ANDAs) have been submitted to the FDA, one of which could be approved by late 2012.
Longer-term efforts center on Rexista™, a novel formulation of oxycodone hydrochloride, an opiate-based analgesic that has gained notoriety due to its widespread abuse.
All Research Reports are in Adobe Acrobat format.
(
For the latest Adobe Acrobat reader click here)
The information and statistical data contained herein have been obtained from sources, which we believe to be reliable but in no way are warranted by us as to accuracy or completeness. We do not undertake to advise you as to changes in figures or our views. This is not a solicitation of any order to buy or sell. Taglich Brothers, Inc. is fully disclosed with its clearing firm, Pershing, LLC, is not a market maker and does not sell to or buy from customers on a principal basis. The above statements are the opinion of Taglich Brothers, Inc. and are not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. There may be instances when fundamental, technical and quantitative opinions contained in the reports are not in concert. We, our affiliates, any officer, director or stockholder or any member of their families may from time to time purchase or sell any of the above-mentioned or related securities. Analysts and members of the Research Department are prohibited from buying or selling securities issued by the companies that Taglich Brothers, Inc. has a research relationship with, except if ownership of such securities was prior to the start of such relationship, then an Analyst or member of the Research Department may sell such securities after obtaining expressed written permission from Compliance. All research issued by Taglich Brothers, Inc. is based on public information. Taglich Brothers, Inc. does not currently have an Investment Banking relationship with the company mentioned and was not a manager or co-manager of any offering for the company within the last three years. In July 2010, the company paid US$6,000.00 representing payment in advance for the creation and dissemination of research reports for three months. The company will pay a total of US$24,000 for minimum of twelve (12) months of such services. For further information and Taglich Brothers, Inc. ownership data please refer to each individual report.
Send to a Friend
To send this page to a friend, just fill out the form below
and press the "send it" button!